TAKE-HOME MESSAGES: CDDF Multi-Stakeholder Workshop – The Critical Role of Biomarkers in Delivering Drug Development-Related Precision Oncology
Read the take-home messages from the CDDF multi-stakeholder workshop on The critical role of Biomarkers in delivering drug development-related precision oncology: SESSION 1: SETTING THE SCENE OF BIOMARKERS Key takeaways: Biomarkers are critical in the diagnosis...
Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Innovative Oncology Trial Design
Watch the interviews with participants from the CDDF Multi-stakeholder Workshop on Innovative Oncology Trial Design (18-19 September 2023, Amsterdam) and gain valuable perspectives from diverse stakeholders in cancer drug development. Collaboration is key to...
CDDF’s New Publication: White Paper – “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”
The CDDF is delighted to announce that the White Paper, “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”, has been published in October 2023. It has been prepared by Prof. Mark Lawler on behalf of the Cancer Drug Development...